ArticleCellular & molecular immunology2021

Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8

Zhen Xun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.